Pretibial Myxedema in a Hypothyroid Patient with Grave’s Disease: A Case Report
Main Article Content
Abstract
Pretibial myxedema, a rare dermatological manifestation primarily associated with Graves' disease, presents as nonpitting edema, nodular, or plaque-like lesions on the lower legs due to accumulation of hyaluronic acid. We present the case of a 42-year-old woman with a history of Graves' disease who developed dark plaques and indurated skin lesions on her shins, extending to the dorsal feet. Diagnosed with Grave’s disease 20 years prior, she underwent subtotal thyroidectomy following antithyroid treatment. Pretibial myxedema developed one-year post-thyroidectomy and was managed with systemic glucocorticoids. She later received iodine-131 therapy, which led to hypothyroidism, and started to admit thyroid hormone replacement. The thyroid function test revealed normal TSH levels and increased TRAbs. Histopathology of skin lesions showed mucopolysaccharide deposition and increased collagen confirming myxedema.
This case highlights the rare elephantiasis form of pretibial myxedema and underscores the importance of recognizing characteristic skin lesions in patients with hypothyroidism.
Article Details
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
2. Ambachew, R.; Yosef, T.; Gebremariam, A. M.; Demere, L.; Aberra, T.; Tarekegn, G.; Reja, A. Pretibial myxedema in a euthyroid patient: a case report. Thyroid Res 2021, 14 (1), 4.
DOI: 10.1186/s13044-021-00096-z From NLM.
3. Chen, M.; Ge, S.; Driscoll, M. Pretibial myxedema in a patient with HIV and hypothyroid to hyperthyroid transformation. JAAD Case Rep 2023, 36, 75-77. DOI: 10.1016/j.jdcr.2023.04.005 From NLM.
4. Nguyen, V. B.; Nguyen, V. V. H.; Van Le, C.; Linh, P. N. T.; Thi, X. N.; Vo, T. T. Pretibial myxedema in Grave's disease: A case report and treatment review of the literature. Clin Case Rep 2024, 12 (2), e8478. DOI: 10.1002/ccr3.8478 From NLM.
5. Schwartz, K. M.; Fatourechi, V.; Ahmed, D. D.; Pond, G. R. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 2002, 87 (2), 438-446. DOI: 10.1210/jcem.87.2.8220 From NLM.
6. Ajjan, R. A.; Weetman, A. P. Techniques to quantify TSH receptor antibodies. Nat Clin Pract Endocrinol Metab 2008, 4 (8), 461-468. DOI: 10.1038/ncpendmet0886 From NLM.
7. Oh, S. Y.; Cho, H. K.; Jung, Y. Y.; Lee, M.-K. A Case of Pretibial Myxedema Associated with Hypothyroidism and Thyroid-Stimulating Hormone Receptor Antibodies. Dermatologica Sinica 2019, 37 (3), 166-169. DOI: 10.4103/ds.ds_51_18.
8. Fatourechi, V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol 2005, 6 (5), 295-309. DOI: 10.2165/00128071-200506050-00003 From NLM.
9. Bruinstroop, E.; Cairo, I.; Drillenburg, P.; van Dam, P. S. Hypothyroidism to Graves' disease and late appearance of pretibial myxoedema. Lancet 2019, 394 (10206), 1364. DOI: 10.1016/s0140-6736(19)32281-0 From NLM.
10. Sabanova, E. A.; Fadeyev, V. V.; Potekaev, N. N.; Lvov, A. N. [Pretibial myxedema: pathogenetic features and clinical aspects]. Probl Endokrinol (Mosk) 2019, 65 (2), 134-138. DOI: 10.14341/probl9848 From NLM.
11. Chen, C. T.; Lin, J. C. Elephantiasic pretibial myxoedema. Indian J Med Res 2013, 137 (3), 568. From NLM.
12. Lan, C.; Wang, Y.; Zeng, X.; Zhao, J.; Zou, X. Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases. J Thyroid Res 2016, 2016, 2652174. DOI: 10.1155/2016/2652174 From NLM.
13. Nair, P. A.; Mishra, A.; Chaudhary, A. Pretibial Myxedema Associated with Euthyroid Hashimoto's Thyroiditis: A Case Report. J Clin Diagn Res 2014, 8 (6), Yd01-02. DOI: 10.7860/jcdr/2014/6581.4415 From NLM.
14. Bartalena, L.; Fatourechi, V. Extrathyroidal manifestations of Graves' disease: a 2014 update. J Endocrinol Invest 2014, 37 (8), 691-700. DOI: 10.1007/s40618-014-0097-2 From NLM.
15. Kahaly, G.; Förster, G.; Hansen, C. Glycosaminoglycans in thyroid eye disease. Thyroid 1998, 8 (5), 429-432. DOI: 10.1089/thy.1998.8.429 From NLM.
16. Lebreton, O.; Seddiki, R.; Abba, S.; Vignes, S. [Pretibial myxedema after Graves' disease: A differential diagnosis of lymphedema]. Rev Med Interne 2023, 44 (12), 641-645. DOI: 10.1016/j.revmed.2023.09.003 From NLM.